Pyk2 uncouples metabotropic glutamate receptor G protein signaling but facilitates ERK1/2 activation by Nicodemo, Alexander A et al.
RESEARCH Open Access
Pyk2 uncouples metabotropic glutamate receptor
G protein signaling but facilitates ERK1/2
activation
Alexander A Nicodemo
1, Macarena Pampillo
1, Lucimar T Ferreira
1, Lianne B Dale
1, Tamara Cregan
1,
Fabiola M Ribeiro
1, Stephen SG Ferguson
1,2*
Abstract
Group I metabotropic glutamate receptors (mGluRs) are coupled via Gaq/11 to the activation of phospholipase Cb,
which hydrolyzes membrane phospholipids to form inositol 1,4,5 trisphosphate and diacylglycerol. This results in
the release of Ca
2+ from intracellular stores and the activation of protein kinase C. The activation of Group I
mGluRs also results in ERK1/2 phosphorylation. We show here, that the proline-rich tyrosine kinase 2 (Pyk2) inter-
acts with both mGluR1 and mGluR5 and is precipitated with both receptors from rat brain. Pyk2 also interacts with
GST-fusion proteins corresponding to the second intracellular loop and the distal carboxyl-terminal tail domains of
mGluR1a. Pyk2 colocalizes with mGluR1a at the plasma membrane in human embryonic kidney (HEK293) cells and
with endogenous mGluR5 in cortical neurons. Pyk2 overexpression in HEK293 results in attenuated basal and ago-
nist-stimulated inositol phosphate formation in mGluR1 expressing cells and involves a mechanism whereby Pyk2
displaces Gaq/11 from the receptor. The activation of endogenous mGluR1 in primary mouse cortical neuron stimu-
lates ERK1/2 phosphorylation. Treatments that prevent Pyk2 phosphorylation in cortical neurons, and the overex-
pression of Pyk2 dominant-negative and catalytically inactive Pyk2 mutants in HEK293 cells, prevent ERK1/2
phosphorylation. The Pyk2 mediated activation of ERK1/2 phosphorylation is also Src-, calmodulin- and protein
kinase C-dependent. Our data reveal that Pyk2 couples the activation mGluRs to the mitogen-activated protein
kinase pathway even though it attenuates mGluR1-dependent G protein signaling.
Background
Glutamate is the predominant excitatory neurotransmit-
ter in the brain and regulates physiological responses
that include the development, survival, and death of
neurons as well as neural plasticity [1-6]. The receptors
that respond to glutamate can be classified into two
types: ionotropic and metabotropic. Ionotropic gluta-
mate receptors are comprised of cation-specific ion
channels that can be subclassified into NMDA, AMPA
and kainate receptors. In contrast, metabotropic gluta-
mate receptors (mGluRs) are coupled to the activation
of heterotrimeric G proteins and the regulation of intra-
cellular second messenger levels. They are subcategor-
ized into three groups based on sequence similarity and
G protein specificity [1]. Group I mGluRs (mGluR1 and
mGluR5) are coupled to Gaq/11 and the activation of
phospholipase Cb which in turn stimulates the forma-
tion of the intracellular second messengers, inositol
1,4,5-triphosphate (InsP3) and diacylglycerol. InsP3 sti-
mulates the release of Ca
2+ from intracellular stores and
both Ca
2+ and diacylglycerol regulate the activation of
protein kinase C (PKC).
Agonist-activated G protein-coupled receptors
(GPCRs) function as guanine nucleotide exchange fac-
tors facilitating the exchange of GDP for GTP on the
Ga subunit. Thus, allowing the dissociation of the Ga
and Gbg subunits, which function to regulate different
effector enzymes and ion channels [7]. The activity of
Group I mGluRs is regulated by protein kinases that
uncouple the receptors from heterotrimeric G proteins
via both phosphorylation-dependent- and phosphoryla-
tion-independent mechanisms [8,9]. Both PKC and G
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Group I mGluR signaling by phosphorylating serine and
threonine residues localized to the intracellular loop and
carboxyl terminal tail domains of the receptors [10-14].
In contrast, the attenuation of both mGluR1 and
mGluR5 signaling by GRK2 is mediated by a phosphory-
lation-independent mechanism that involves the interac-
tion of the GRK2 amino terminal regulator of G protein
signaling homology domain with Gaq/11 resulting the
displacement of the heterotrimeric G protein from the
receptor [9,15]. Recently, we have demonstrated that
optineurin and calcineurin inhibitory protein (CAIN)
can also contribute to the phosphorylation-independent
attenuation of Group I mGluR signaling by a mechan-
ism that also involves Gaq/11 displacement from the
receptor [16,17].
A number of studies have also implicated tyrosine
kinases in the regulation of Group I mGluR signaling.
For example, Canepari et al [18] have reported that
inhibitors of tyrosine phosphorylation enhance mGluR1-
mediated cation-permeable ion channel conductances at
parallel fibers that synapse on Purkinje neurons in the
cerebellum of the rat. In contrast, G protein-dependent
inward currents in midbrain dopaminergic neurons acti-
vated by mGluR1 are antagonized by tyrosine kinase
inhibitors [19]. A potential candidate tyrosine kinase
that is involved in the regulation of Group I mGluR sig-
naling is proline-rich tyrosine kinase 2 (Pyk2), which is
found in a multimolecular complex with both mGluR1
and the NMDA receptor [20]. Heidinger and coworkers
[21] have also demonstrated that mGluR1-mediated
upregulation of NMDA receptor currents in cortical
neurons involves a Ca
2+-, calmodulin- and Src-depen-
dent activation of Pyk2. We show here that Pyk2 can be
co-immunoprecipitated with both mGluR1 and mGluR5
from rat brain lysates and that Pyk2 interacts directly
with Group I mGluRs via their second intracellular loop
and carboxyl-terminal tail domains. We also find that
Pyk2 expression attenuates mGluR1a signaling by dis-
rupting receptor/Gaq/11 interactions, but functions to
couple mGluR1 to the activation of extracellular regu-
lated kinase 1/2 (ERK1/2) in cortical neurons.
Methods
Materials
Human embryonic kidney (HEK293) cells and COS-7
cells were obtained from the American Type Culture
Collection (Manassas, VA, USA). Tissue culture reagents
were purchased from Invitrogen (Burlington, ON,
Canada). Isopropyl-b-D-thiogalactopyranoside (IPTG)
was obtained from Bioshop Canada Inc (Mississauga,
ON, Canada). Quisqualate, DHPG, MPEP and LY367385
were purchased from Tocris Cookson Inc. (Ellisville,
MO, USA). [
3H]myo-inositol was acquired from
PerkinElmer Life Sciences (Woodbridge, ON). The
Dowex 1-X8 (formate form) resin with 200-400 mesh
was purchased from Bio-Rad. Horseradish peroxidase-
conjugated anti-mouse and anti-rabbit IgG secondary
antibodies, protein G-Sepharose beads, enhanced chemi-
luminescence (ECL), and mouse monoclonal anti-
hemagglutinin (HA) (12CA5) antibody were purchased
from GE Healthcare (Oakville, ON Canada). Anti-GST
mouse monoclonal antibody and anti-Gaq/11 rabbit poly-
clonal antibody were from Santa Cruz Biotechnology
Inc. (Santa Cruz, CA, USA). Anti-mGluR5 rabbit poly-
clonal antibody was obtained from Upstate (Lake Placid,
NY, USA). Anti Pyk2/CAKb mouse monoclonal anti-
body was from BD Transduction Laboratories (Missis-
sauga, ON, Canada). Rabbit polyclonal phospho-p44/44
MAP kinase (Thr202/Tyr402), p44/44 MAP kinase,
phospho-Pyk2 (Tyr402) antibody, phospho-Pyk2
(Tyr457), Pyk2, phosphor-Src (Tyr 416) and Src antibo-
dies were all obtained from Cell Signaling Technology.
(Pickering, ON, Canada). Lipofectamine Alexa Fluor 488
goat anti-mouse IgG and Alexa Fluor 568 goat anti-rab-
bit IgG were purchased from Invitrogen/Molecular
Probes (Burlington, ON, Canada). siRNAs were pur-
chased from Dharmacon RNAi Technologies (Lafayette,
CO, USA). Hi-Perfect Transfection Reagent was pur-
chased from Qiagen (Misssauga, ON, Canada). All other
biochemical reagents were purchased from Sigma (Oak-
ville, ON, Canada), Fisher Scientific (Ottawa, ON,
Canada) and VWR Scientific (Mississauga, ON, Canada).
Plasmid construction
T h ec D N Af o rt h eh u m a nP y k 2was first amplified by
PCR from the human universal Quick Clone™ library
and tagged with a hemagglutanin (HA) epitope tag (BD
Biosciences/Clontech, Mississauga, ON, Canada). The
PCR product generated was digested with SalI/XbaI and
subcloned into a mammalian expression HA vector. All
other cDNA constructs have been described previously
[12,17].
Cell Culture and transfection
HEK293 cells were maintained in Eagle’s minimal essen-
tial medium supplemented with fetal bovine serum (8%
v/v) and gentamicin (5 μg/ml). African green monkey
(COS7) cells were grown at 37°C in Dulbecco’s modified
Eagle’s medium supplemented with fetal bovine serum
(8% v/v) and gentamicin (5 μg/ml). Cells were trans-
fected using a modified calcium phosphate method as
described previously [22]. Following transfection (18 h),
the cells were incubated with fresh medium and allowed
to recover for 24 h for coimmunoprecipitation studies.
Otherwise, they were allowed to recover for 6-8 h and
reseeded into either 12-well dishes coated with collagen
or containing collagen-coated coverslips, or into 24-well
dishes and then grown an additional 18 h prior to
experimentation.
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cortex of embryonic day 15 CD1 mouse embryos. Cells
were plated on either 100 mm dishes or 15 mm glass
coverslips coated with poly-L-ornithine (Invitrogen) in
Neurobasal media with B-27 (Gibco) and N2 (Gibco)
supplements, 2 mM glutamax, 50 μg/ml penicillin, 50
mg/ml streptomycin. Cells were incubated at 37°C and
5% CO2 in a humidified incubator and cultured for up
to 21 days in vitro with media replenishment every 3
days. Rat primary cortical cultures were cultured as
described for primary mouse cultures and were prepared
from the cortex of embryonic day 20 Wistar rat
embryos. All animal procedures were approved by the
University of Western Ontario Animal Care Committee.
siRNA Transfection
After a growth period of 4 days, primary mouse cortical
neurons growing in 6-well or 12-well plates were trans-
fected with 100 nM of Pyk2 siRNA (GAACATGGCT-
GACCTCATATT) using Hi-Perfect Transfection
Reagent according to the manuscfacturer’s specifications
(Qiagen, Mississauga, ON). After two days, the cells
were transfected again in the exact same manner. The
next day, the neurobasal media was aspirated, and the
cells were washed twice with HBSS and left overnight in
HBSS supplemented with bovine serum albumin Frac-
tion V. For COS7 cells Pyk2 siRNA (GGACGAGGAC-
TATTACAAA) was transfected with Lipofectamine
2000 following manufacturer’s instructions. Scrambled
siRNA (Non-Targeting siRNA #1) was purchased from
Dharmacon. Experiments were performed 48 or 72
hours after transfection and knock down of proteins was
confirmed by western blot.
Co-immunoprecipitation
Coimmunoprecipitation experiments were performed
using 500-1000 μg of total cell lysate protein solubilized
from HEK293 cells transiently transfected with the var-
ious cDNA constructs as described in the Figure
Legends. The cells were solubilized in lysis buffer (25
mM HEPES, pH 7.5, 300 mM NaCl, 1.5 mM MgCl2, 0.2
mM EDTA and 0.1% Triton X-100) containing protease
inhibitors. Phosphorylated Pyk2 was examined in the
presence of 1 mM sodium vanadate, 100 μMG D P ,2
mM MgSO4, 30 μM aluminum chloride, and 5 mM
sudium fluoride. FLAG-mGluR1a was immunoprecipi-
tated with FLAG Sepharose beads from cell lysates by
overnight rotation at 4°C. For the coimmunoprecipita-
tion of endogenous proteins from whole-brain extracts,
adult rat brains were employed. Tissue was dissected
and homogenized on ice in lysis buffer containing pro-
tease inhibitors. The particulate fraction was removed
by centrifugation and 500-1000 μg of supernatant pro-
tein was incubated with polyclonal anti-mGluR1a or
anti-mGluR5a rabbit antibodies and protein G-sepharose
beads by overnight rotation at 4°C. For HEK293 and rat
brain co-immunoprecipitations, the beads were washed
4-6 times with lysis buffer, and proteins were eluted in
SDS loading buffer by boiling for 3-5 min. Eluted sam-
ples were separated by SDS-PAGE, followed by electro-
blotting onto nitrocellulose membranes for
immunoblotting. Immunoblots were visualized by che-
miluminescence using an ECL kit. Intensities of immu-
noblot signals were determined with the 4.0.2 version of
the data acquisition and analysis software from Scion
Corp. (Frederick, MD, USA).
Confocal microscopy and Immunostaining
Confocal microscopy was performed using a Zeiss LSM-
510 META laser scanning confocal microscope
equipped with a Zeiss 63X, 1.4 numerical aperture, oil
immersion lens (North York, ON, Canada). HEK293
cells expressing both HA-Pyk2 and FLAG-mGluR1a as
well as primary rat cortical neurons were seeded on 15
mm glass coverslips. HEK293 cells were serum starved
for 30 min at 37°C in HBSS (116 mM NaCl, 20 mM
HEPES, 11 mM glucose, 5 mM NaHCO3, 4.7 mM KCl,
2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, pH
7.4). HEK293 cells were prelabeled with Alexa Fluor
568-conjugated anti-FLAG polyclonal rabbit antibody.
Cells were then either kept on ice or stimulated with
100 μM quisqualate for 30 min at 37°C. Subsequently,
the cells were fixed with 4% paraformaldehyde and per-
meabilized with 0.05% Triton X-100, and labeled with
Alexa Fluor 568-conjugated anti-HA mouse monoclonal
antibody. Primary rat cortical neurons were fixed with
4% paraformaldehyde and permeabilized with 0.05% Tri-
ton X-100, and then stained for endogenous mGluR5a
and Pyk2 with rabbit polyclonal anti-mGluR5a antibody
and mouse monoclonal anti-Pyk2/CAKb antibody. Cov-
erslips were mounted in IMMU-MOUNT (Thermo
Shandon, Pittsburgh, PA) onto glass slides and allowed
to air dry before viewing. Colocalization studies were
performed using dual excitation (488, 543 nm) and
emission (band pass 505-530 nm and long pass 560 nm
for Alexa Fluor 488 and 568, respectively) filter sets.
The specificity of labeling and absence of signal cross-
over were established by examination of single-labeled
samples.
GST-mGluR1a fusion protein purification and pull down
assays
GST-mGluR1a peptides were generated by growing
recombinant Escherichia coli BL21 bacteria at 37°C to
an A600 of 0.65-0.8. Bacterial cultures were then induced
for 3 hrs with 1 mM IPTG. After induction, cultures
were pelleted, resuspended in PBS containing protease
inhibitors and lysed by mild sonication. The bacterial
lysates were cleared of cellular debris by centrifugation
and then incubated with to glutathione-Sepharose 4B
resin overnight at 4°C. GST-mGluR1a peptides bound to
the matrix were washed extensively in PBS and then
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tors. COS-7 cell lysates overexpressing HA-Pyk2 were
prepared and cleared of cellular debris by centrifugation.
400 μg of total cell lysate protein was used in each pull-
down assay. One μg of matrix-bound mGluR1a peptides
were incubated together with COS7 cell lysates and
mixed overnight on an orbital shaker at 4°C. The
matrix-bound protein complexes were washed exten-
sively in lysis buffer and then eluted off the matrix in
SDS loading buffer by boiling for 3-5 mins. Eluted sam-
ples were analyzed by SDS-PAGE and Western blotting
with anti-Pyk2.
Inositol Phosphate Formation
Inositol lipids were radiolabeled by incubating HEK293
cells overnight with 1 μCi/ml [
3H]myo-inositol in Dul-
becco’s modified Eagle’s medium. Unincorporated [
3H]
myo-inositol was removed by washing the HEK293 cells
with HBSS. HEK293 cells were preincubated for 1 h in
HBSS at 37°C and then preincubated in 500 μlo ft h e
same buffer containing 10 mM LiCl for an additional 10
min at 37°C. HEK293 cells were subsequently treated in
either the absence or the presence of increasing concen-
trations (0-30 μM) of quisqualate for 30 min at 37°C.
The reaction was stopped on ice by adding 500 μlo f0 . 8
M perchloric acid and then neutralized with 400 μlo f
0.72 M KOH, 0.6 M KHCO3. The total [
3H]myo-inosi-
tol incorporated into the cells was determined by count-
ing the radioactivity present in 50 μl of the cell lysate.
Total inositol phosphate was purified from the cell
extracts by anion exchange chromatography using
Dowex 1-X8 (formate form) 200-400 mesh anion
exchange resin. [
3H]Inositol phosphate formation was
determined by liquid scintillation using a Beckman LS
6500 scintillation system.
Receptor internalization
Agonist-independent FLAG-mGluR1a internalization
was measured by flow cytrometry. Cell surface epitope-
tagged receptors were prelabeled with primary anti-
mouse FLAG antibody (1:500) on ice for 45 min. Cells
were then warmed to 37°C in the absence of agonist for
the times indicated in the Figure Legends. Cells were
then transferred back on ice and labeled with secondary
FITC-conjugated anti-mouse IgG antibody (1:500 dilu-
tion) for 45 min. Under these conditions, receptors are
able to undergo only a single round of internalization.
Receptor internalization is defined as the fraction of
total cell receptors lost from the cell surface and thus is
not available for labeling with the secondary antibody.
ERK1/2 and Pyk2 immunoblots
100 μg samples of cell lysate proteins solubilized from
either HEK293 cells, COS7 cells or mouse primary cor-
tical neurons were subjected to were subjected to SDS-
PAGE, followed by electroblotting onto nitrocellulose
membranes for immunoblotting with antibodies
described in the Figure Legends. The primary antibodies
used in the experiments were phospho-p44/44 MAP
kinase (Thr202/Tyr402) antibody (diluted 1:1000), p44/
44 MAP kinase antibody (1:1000), phospho-Pyk2
(Tyr402) antibody (1:1000), phospho-Pyk2 (Tyr457)
antibody (1:1000), Pyk2 antibody (1:1000), rabbit anti-
Flag antibody (1:1000). Antibody reactive bands were
visualized and quantified as described above.
Data Analysis
The means ± S.E.M. are shown for values obtained for the
number of independent experiments indicated in the fig-
ure legends. GraphPad Prism software (Graph Pad, San
Diego, CA) was used to analyze data for statistical signifi-
cance, as well as to analyze and fit dose-response and time
course data. The statistical significance was determined by
either one way analysis of variance or t-test.
Results
Interaction between Pyk2 and mGluR1
It was previously reported that both Pyk2 and mGluR1a
were components of a protein complex that could be
co-immunoprecipitated with the NMDA receptor [20].
Moreover, it was shown that mGluR1a activation altered
NMDA receptor currents in a Pyk2-dependent manner
[21]. Therefore, we tested whether HA-Pyk2 could be
co-immunoprecipitated from HEK293 cells with FLAG-
mGluR1a. We found that HA-Pyk2 was co-immunopre-
cipitated with FLAG-mGluR1 in the absence of agonist
and agonist treatment for 20 min reduced the amount
of HA-Pyk2 co-immunoprecipitated with FLAG-
mGluR1a to 24 ± 6% of control (Fig. 1A and 1B). We
also found that endogenous Pyk2 could be co-immuno-
precipitated with either mGluR1 or mGluR5 from rat
whole brain lysates (Fig. 1C). To assess whether HA-
Pyk2 interacted directly with mGluR1a, we tested the
ability of GST fusion proteins encoding either the sec-
ond intracellular loop (IL2) or carboxyl terminal tail
(CTC) domains of mGluR1a to co-precipitate HA-Pyk2
from COS7 cell lysates. We found that HA-Pyk2 bound
to both the GST-IL2 and GST-CTC fusion proteins
(Fig. 1D). HA-Pyk2 could be co-immunoprecipitated
with both a mGluR1a mutant (mGluR1a-866Δ)a n dt h e
mGluR1b splice variant that lack the extended carboxyl-
terminal tails and the association of HA-Pyk2 was
decreased following agonist treatment (Fig. 1E). Taken
together, these results indicated that Pyk2 forms a com-
plex with Group I mGluRs by binding to the IL2 and
carboxyl terminal tail domains of the receptors, but that
the distal portion of the mGluR1a carboxyl-terminal
tails was not essential for Pyk2 interactions with the
receptor.
Colocalization of Pyk2 and mGluR1
Because Pyk2 can be co-immunoprecipitated with
mGluR1a, we examined whether Pyk2 was colocalized
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mary rat cortical neurons. HEK293 cells expressing
FLAG-mGluR1a and HA-Pyk2 were labeled on ice with
Alexa Fluor 568-congugated FLAG antibody and treated
either with or without 100 μM quisqualate for 45 min at
37°C. Subsequently, the cells were fixed and permeabi-
lized and labeled with Alexa Fluor 488-conjugated HA
antibody to stain HA-Pyk2. In the absence of agonist
stimulation, FLAG-mGluR1a was localized to the cell
surface and although HA-Pyk2 was expressed
throughout the cytoplasm, Pyk2 was also localized at
the plasma membrane (Fig. 2A). In response to agonist
treatment, cell surface FLAG-mGluR1a was internalized
to intracellular vesicles, but HA-Pyk2 was not observed
to internalize as a complex with the receptor (Fig. 2B).
W ea l s of o u n dt h a tp r i m a r yr a tc o r t i c a ln e u r o n s ,w h i c h
stained positive for either endogenous mGluR1a or
mGluR5 expression, also stained positive for the expres-
sion of Pyk2 protein (Fig. 2C and 2D). Consistent with
the observation that HA-Pyk2 does not internalize with
Figure 1 Pyk2 interacts with Group I mGluRs. A) Representative immunoblot showing the co-immunoprecipitation of HA-Pyk2 with Flag-
mGluR1a from HEK293 treated with 30 μM quisqualate for 0, 10, and 20 min. FLAG-mGluR1a is immunopreciptated from 500-1000 μg of protein
lysate. The expression of HA-Pyk2 is shown in input lanes correspond to 100 μg of protein lysate. B) The densitometric analysis of
autoradiographs showing the mean ± SD of 5 independent experiments examining the co-immunoprecipitation of HA-Pyk2 with FLAG-mGluR5.
* P < 0.05 versus untreated cells. C) Representative immunoblotblot showing the co-immunoprecipitation of Pyk2 with mGluR1 and mGluR5
polyclonal antibodies from either 1000 or 500 μg of rat whole brain lysates. The blot is representative of 3 independent experiments. D)
Representative immunoblot of HA-Pyk2 co-precipitated with 1 μg of GST, and GST fusion proteins encoding either the second intracellular loop
domain of mGluR1 (GST-IL2) or the distal region of the carboxyl-terminal tail domain of mGluR1a (GST-CTC). The GST fusions are incubated with
400 μg of COS-7 cell lysates expressing HA-Pyk2. The expression of HA-Pyk2 is shown in input lanes correspond to 100 μg of protein lysate. E)
Representative immunoblot showing the co-immunoprecipitation of HA-Pyk2 with either Flag-mGluR1a-866Δ or FLAG-mGluR1b and HA-Pyk2
and treated with 30 μM quisqualate for 0 and 30 min. FLAG-mGluR1 protein is immunopreciptated from 500-1000 μg of protein lysate. The
expression of HA-Pyk2 is shown in input lanes correspond to 100 μg of protein lysate. Data are representative of 4 independent experiments.
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not alter the extent of agonist-independent FLAG-
mGluR1a internalization (Fig. 3).
Pyk2-mediated attenuation of mGluR1a signaling
Since we established that Pyk2 interacted with mGluR1,
we tested whether this association affected mGluR1a-
mediated inositol phosphate (IP) formation in HEK293
cells expressing FLAG-mGluR1a. We found that in the
absence of agonist-treatment HA-Pyk2 reduced basal IP
formation in FLAG-mGluR1a expressing HEK293 cells
to 69 ± 6% of control values (Fig. 4A). Similarly, the
overexpression of HA-Pyk2 reduced the maximal
FLAG-mGluR1a-mediated responses to increasing con-
centrations of quisqualate to 75 ± 7% of control values
and induced a 2.9 fold rightward shift in the EC50 for
quisqualate-stimulated IP formation (EC50 =2 6n Mv s
76 nM) (Fig. 4B). Previously, we demonstrated that both
GRK2 and CAIN attenuated mGluR1a signaling by com-
peting with Gaq/11 f o rb i n d i n gt oI L 2o fm G l u R 1 a
[9,17]. Therefore, we examined whether the overexpres-
sion of HA-Pyk2 also disrupted Gaq/11 interactions with
FLAG-mGluR1a. In cells expressing HA-Pyk2, HA-Pyk2
was co-immunoprecipitated with FLAG-mGluR1a and
resulted in a decrease in Gaq/11 co-immunoprecipitated
with the receptor complex (Fig. 4C). The receptor Gaq/
11 complex was also regulated in both the presence and
absence of HA-Pyk2 by GDP-ALF4-,w h i c hb i n d st o
Gaq/11 and mimics the Gaq/11 transition state (Fig. 4C).
M o r e o v e r ,w ew e r eu n a b l et od e m o n s t r a t et h a tP y k 2
overexpression led to mGluR1a tyrosine phosphorylation
(data not shown). Thus, taken together, these results
demonstrated that Pyk2 contributed to the regulation of
mGluR1a signaling by antagonizing receptor interactions
with Gaq/11.
mGluR1 mediates ERK1/2 phosphorylation by a Src/Pyk2-
dependent pathway
A previous study demonstrated that mGluR1 regulated
NMDA receptor currents via the activation of a Pyk2/
Src-family kinase pathway [21]. Therefore, we examined
whether Pyk2 regulated mGluR1-mediated ERK1/2
phosphorylation in addition to heterotrimeric G protein
coupling. The treatment of primary mouse cortical neu-
rons with 50 μM (S)-3,5-dihydroxylphenylglycine
(DHPG) resulted in a rapid 2.2 ± 0.5 fold increase in
ERK1/2 phosphorylation within 1-5 min of agonist treat-
ment (Fig. 1A). DHPG-stimulated ERK1/2 phosphoryla-
tion could be blocked by the mGluR1-specific
antagonist LY367385 (Fig. 5B), but was unaffected by
the treatment of cortical neurons with the mGluR5-spe-
cific antagonist MPEP (Fig. 5C). Therefore, ERK1/2
phosphorylation in primary mouse cortical neurons was
selectively activated by mGluR1, despite the fact that
both mGluR1 and mGluR5 subtypes are expressed in
cortical tissue and cell culture [15].
To examine whether mGluR1a-mediated ERK1/2
phosphorylation was mediated by Src/Pyk2-mediated
pathway, we pretreated primary mouse cortical neurons
with and without the Src family kinase inhibitor PP2 (10
μM) for 60 min prior to treating the neurons with and
without 50 μM DHPG. We found that, in the presence
of the Src inhibitor, DHPG-stimulated ERK1/2 phos-
phorylation was effectively inhibited (Fig. 6A). We also
observed that Pyk2 was phosphorylated in the absence
of agonist and that DHPG treatment did not result in
any further increase in Pyk2 phosphorylation (Fig. 6B).
However, the treatment of the cortical neurons with
PP2 completely suppressed Pyk2 (Y402) phosphorylation
under both basal and agonist-stimulated conditions (Fig.
6B). Identical results were obtained when Src phosphor-
ylation was examined (Fig. 6C). Thus, taken together the
data indicated that Src activity was required for
mGluR1-stimulated ERK1/2 phosphorylation and that
suppression of Src activity resulted in an attenuation of
Pyk2 phosphorylation.
Tyrphostin A9 was previously demonstrated to be the
most effective amongst an array of 51 tyrosine kinase
inhibitors in antagonizing Pyk2 activity in neutrophils
[ 2 3 ] .T h e r e f o r e ,t oe x a m i n ear o l ef o rP y k 2i nc o u p l i n g
mGluR1 to the activation of ERK1/2 phosphorylation,
we utilized tyrphostin A9 to antagonize Pyk2 activity.
T h et r e a t m e n to fm o u s ep r i m a r yn e u r o n sw i t h1 0μM
tyrphostin A9 for 10 min prior to agonist treatment
effectively prevented ERK1/2 phosphorylation in
response to 50 μM DHPG treatment (Fig. 7A). Consis-
tent with an effect of tyrphostin A9 on Pyk2 activity,
Pyk2 phosphorylation in either the absence or presence
of DHPG was completely inhibited by the drug (Fig.
7B). Since tyrphostin A9 was not entirely selective for
the antagonism of Pyk2 activity, we also examined the
effect of a calmodulin antagonist calmidazolium chloride
on mGluR1-stimulated ERK1/2 phosphorylation. Calmi-
dazolium chloride was tested because Pyk2 was shown
previously to be activated via a Ca
2+-calmodulin depen-
dent pathway in non-neuronal cells [24]. The pretreat-
ment of cortical neurons with 30 μMc a l m i d a z o l i u m
chloride for 10 min also prevented DHPG-stimulated
increases in ERK1/2 phosphorylation (Fig. 7C) and com-
pletely antagonized Pyk2 phosphorylation in either the
absence or presence of DHPG (Fig. 7D). DHPG-
mediated activation of ERK1/2 phosphorylation was also
dependent upon PKC activation, as the treatment of
cortical neurons with staurosporine blocked both ERK1/
2 phosphorylation in response to agonist treatment (Fig.
8A) and reduced Pyk2 phosphorylation in either the
absence or presence of DHPG (Fig. 8B).
To further probe the role of Pyk2 in the activation of
ERK1/2 by mGluR1, we utilized siRNA to knockdown
endogenous Pyk2 expression in primary mouse cortical
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Page 6 of 17Figure 2 Pyk2 colocalizes with Group I mGluRs in HEK 293 cells and in primary mouse cortical neurons. Shown are representative
confocal micrographic images of HEK293 cells showing the distribution of HA-Pyk2 and FLAG-mGluR1a distribution in either A) the absence of
agonist treatment or B) following treatment with 100 μM quisqualate for 30 min. Cells are transfected with 1 μg of pcDNA3.1 plasmid cDNA
encoding HA-Pyk2 and 5 μg of pcDNA3.1 plasmid cDNA encoding FLAG-mGluR1 and are stained with Alexa Fluor-conjugated 568 rabbit
polyclonal anti-Flag antibody and Alexa Fluor 488-conjugated mouse monoclonal anti-HA antibody at 4°C. The data is representative 3
independent experiments. Shown are representative confocal micrographic images of primary rat cortical neurons fixed in 4% paraformaldehyde
and stained with either Alexa Flour 568-conjugated rabbit polyclonal anti-mGluR1a (C) or mGluR5 (D) antibody and Alexa Fluor 488-conjugated
polyclonal rabbit anti-Pyk2 antibody. The micrograph is representative of 3 independent experiments. Scale bars, 10 μm.
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Page 7 of 17neurons. Pyk2 siRNA treatment of cortical neurons
resulted in a 66 ± 5% decreases in Pyk2 expression (Fig.
9A). However, unlike what was expected the reduction
in Pyk2 protein expression resulted in an increase in
basal ERK1/2 phosphorylation to levels that were
observed following mGluR1 activation with DHPG (Fig
9B). This increase in basal ERK/12 phosphorylation fol-
lowing Pyk2 siRNA treatment was also associated with
an increase in the relative phosphorylation of the
remaining Pyk2 protein expressed in the cortical neu-
rons (Fig. 9C). To examine whether the increase in basal
ERK1/2 phosphorylation was attributable to mGluR1
activity, we examined the effect of siRNA knockdown of
Pyk2 in COS7 cells in the absence and presence of
FLAG-mGluR1a expression. Pyk2 protein expression
was reduced to 47 ± 5% in cells treated with Pyk2
siRNA alone when compared to cells treated with a
scramble siRNA and in cells transfected with both
FLAG-mGluR1a and Pyk2 siRNA, Pyk2 expression was
further reduced to 16 ± 7% of control (Fig. 9D). In cells
expressing FLAG-mGluR1a and treated with scrambled
siRNA ERK1/2 phosphorylation was increased without a
significant change in the extent of Pky2 phosphorylation
in response DHPG treatment (Fig. 9E and 9F). In COS7
cells treated with Pyk2 siRNA alone (no FLAG-
mGluR1a), Pyk2 phosphorylation was substantially
increased, but no change in ERK1/2 phosphorylation
was observed (Fig. 9E and 9F). However, the transfection
of COS7 cells with both Pyk2 siRNA and FLAG-
mGluR1a resulted in an even greater increase in Pyk2
phosphorylation and was associated with a substantial
increase in basal ERK1/2 phosphorylation (Fig. 9E and
9F). Taken together, these observations indicated that
the increased basal ERK1/2 phosphorylation observed
following Pyk2 siRNA treatment was likely attributable
to the basal activity of mGluR1.
To establish a direct role for Pyk2 in mGluR1a-
mediated ERK1/2 phosphorylation, we examined the
effect of overexpressing wild-type Pyk2, a dominant
negative Pyk2 (Y402F) mutant and a catalytically inac-
tive Pyk2 (K457A) mutant on FLAG-mGluR1 signaling
in HEK293 cells. We found that FLAG-mGluR1a activa-
tion with 100 μM quisqualate resulted in a 2.4 ± 0.4
fold increase in ERK1/2 phosphorylation in the absence
of Pyk2 overexpression (Fig. 10A and 10B). Overexpres-
sion of HA-Pyk2 alone (no FLAG-mGluR1a) had no
effect on either basal or quisqualate-stimulated ERK1/2
phosphorylation in the absence of FLAG-mGluR1a
expression. However, overexpression of HA-Pyk2 with
FLAG-mGluR1a resulted in a 4.1 ± 0.7 fold increase in
basal ERK1/2 expression,w h e nc o m p a r e dt ob a s a l
ERK1/2 phosphorylation in cells expressing FLAG-
mGluR1a alone (Fig. 10A and 10B). Furthermore, ago-
nist stimulation with quisqualate did not result in a
Figure 3 Pyk2 expression has no effect on agonist-independent receptor internalization. HEK293 cells transfected with 5 μg of pcDNA3.1
cDNA encoding FLAG-mGluR1a with and without either 5 μg of empty pcDNA3.1 plasmid cDNA or 5 μg of pcDNA3.1 plasmid cDNA encoding
HA-Pyk2 were treated with and without 100 μM quisqualate for different time points. The data represent the mean ± S.E.M. of 9 independent
experiments.
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Page 8 of 17substantial increase in ERK1/2 phosphorylation follow-
ing the overexpression of HA-Pyk2 (Fig. 10A and 10B).
In contrast, overexpression of either a dominant-nega-
tive Pyk2-Y402F mutant or catalytically inactive Pyk2-
K457A mutant prevented FLAG-mGluR1a-stimulated
increases in ERK1/2 phosphorylation (Fig. 10A and
10B). The overexpression of Pyk2-K457A also resulted
in reduced basal ERK1/2 phosphorylation (Fig. 10A and
10B). Taken together, these data indicated that in addi-
tion to contributing to the uncoupling of mGluR1 from
Gaq/11, Pyk2 was required for mGluR1-dependent acti-
vation of ERK1/2 signaling.
Discussion
In the present study, we provide evidence that the non-
receptor tyrosine kinase Pyk2 interacts with and regu-
lates mGluR1a signaling and desensitization. Pyk2
associates with the second intracellular loop domain and
the carboxyl-terminal tail domains of mGluR1a, and
similar to what has been described for GRK2, optineurin
and CAIN, Pyk2 functions to disrupt Gaq/11 interactions
with the receptor resulting in the attenuation of IP for-
mation [9,16,17]. However, Pyk2 also facilitates
mGluR1a-mediated activation of the ERK1/2 pathway,
an effect that also requires the activity of Src, calmodu-
lin and PKC. Thus, we describe a new mechanism by
which Pyk2 attenuates mGluR1a by disrupting
mGluR1a/Gaq/11 interactions, while simultaneously cou-
pling the receptor to the activation of the mitogen-acti-
vated protein kinase (MAPK) signaling pathway.
Pyk2 is a non-receptor tyrosine kinase that is known
to be activated by stimuli that either increase intracellu-
lar Ca
2+ concentrations or activate PKC in response to
stress signals, such as UV light, hyperosmotic shock and
tumor necrosis factor-a [25]. Pyk2 has also been shown
to be involved in G protein-coupled-receptor signaling.
For example, Felsch et al. [26] reported that Pyk2 phos-
phorylates the potassium channel Kv1.2 in response to
the activation of m1 muscarinic acetylcholine receptor.
In vascular smooth muscle cells, angiotensin II stimu-
lates the association of Janus kinase 2 with the angioten-
sin II type1 receptor via a mechanism that involves
increases in intracellular Ca
2+ concentrations and the
activation of both PKCδ and Pyk2 [27]. Similarly, Hei-
dinger et al. [21] showed that Pyk2 is involved in the
mGluR1-mediated phopshorylation of NR2A/B subunits
of the NMDA receptor in cortical neurons. Moreover,
in HEK293 cells both the a1B-o ra2A-adrenergic recep-
tors stimulate ERK1/2 phosphorylation via a Ca
2+-, cal-
modulin-, Src- and Pyk2-dependent pathway [24]. In the
present study, we provide evidence that Pyk2 interacts
with mGluR1a and plays a role in of the mGluR1a-
dependent activation of ERK1/2 phosphorylation via a
mechanism that also requires calmodulin, Src, and PKC
Figure 4 Effect of Pyk2 expression on mGluR1a signaling.
HEK293 cells transfected with 5 μg of pcDNA3.1 cDNA encoding
FLAG-mGluR1a with and without either 5 μg of empty pcDNA3.1
plasmid cDNA or 5 μg of pcDNA3.1 plasmid cDNA encoding HA-
Pyk2 were assessed for IP formation in either A) the absence of
agonist stimulation or B) in response to increasing concentrations
of quisqualate (10
-8.5-10
-4.5M). The agonist dose-response curves
were fit and analyzed using GraphPad Prism software. The data
points represent the mean ± SEM for 10 independent experiments.
*P < 0.05 versus control cells. C) Representative immunoblot
showing the effect of HA-Pyk2 expression and GDP-ALF4- treatment
on Gaq/11 co-immunoprecipitation with FLAG-mGluR1a. The data
points represent the mean ± SD for 4 independent experiments. * P
< 0.05 versus untreated cells.
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the absence of agonist treatment and the mGluR1a/Pyk2
protein complex dissociates in response to quisqualate
treatment for 20 min. The physiological consequence of
this dissociation is unclear, but it is possible that the
loss of Pyk2 from the receptor may occur as the result
GRK2 binding to the receptor, which like mGluR5
might be required for agonist-stimulated mGluR1a
endocytosis [33]. Consistent with this hypothesis and
the observation that Pyk2 dissociates from the receptor
in response to agonist activation, we do not observe
Pyk2 internalization with mGluR1a.
Pyk2 has previously been demonstrated to be autop-
hosphorylated on Tyr402 in response to the activation
of the G protein-coupled lysophosphatidic acid receptor
resulting in the creation of a docking site for the Src
Figure 5 ERK1/2 phosphorylation in mouse cortical neurons is mGluR1-dependent. A) Representative immunoblot of the time course for
ERK1/2 phosphorylation in primary mouse cortical neurons treated with 50 μM DHPG. Bar graph shows the denstiometric analysis of the time
course of DHPG-stimulated ERK1/2 phosphorylation in cortical neurons. The data represents the mean ± SD of four independent experiments. *
P < 0.05 versus untreated cells. B) Representative immunoblot showing the effect of treating primary mouse cortical neurons with and without
50 μM DHPG for 5 min following pretreatment either with or without the mGluR1-selective antagonist LY367385 (100 μM) on ERK1/2
phosphorylation. Bar graph shows the mean ± SD of five independent experiments. C) Representative immunoblot showing the effect of
treating primary mouse cortical neurons with and without 50 μM DHPG for 5 min following pretreatment either with or without the mGluR5-
selective antagonist MPEP (10 μM) on ERK1/2 phosphorylation. Bar graph shows the mean ± SD of four independent experiments. * P < 0.05
versus untreated mGluR1a expressing cells.
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Page 10 of 17Figure 6 Effect of the Src inhibitor PP2 on ERK1/2, Pyk2 and Src phosphorylation in cortical neurons. A) Representative immunoblot
showing the effect of treating primary mouse cortical neurons with and without 50 μM DHPG for 5 min and pretreated either with or without
the Src inhibitor PP2 (10 μM) on ERK1/2 phosphorylation. B) Representative immunoblot showing the effect of treating primary mouse cortical
neurons with and without 50 μM DHPG for 5 min and pretreated either with or without the Src inhibitor PP2 (10 μM) on Pyk2 (Y402)
phosphorylation. B) Representative immunoblot showing the effect of treating primary mouse cortical neurons with and without 50 μM DHPG
for 5 min and pretreated either with or without the Src inhibitor PP2 (10 μM) on Src (Y416) phosphorylation. Bar graph shows the mean ± SD of
four independent experiments. * P < 0.05 versus untreated mGluR1a expressing cells.
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Page 11 of 17Figure 7 Effect of tyrphostin A9 and calmidazolium chloride on ERK1/2 and Pyk2 phosphorylation in cortical neurons. A)
Representative immunoblot showing the effect of treating primary mouse cortical neurons with and without 50 μM DHPG for 5 min and
pretreated either with or without tyrphostin A9 (10 μM) on ERK1/2 phosphorylation. Bar graph shows the mean ± SD of nine independent
experiments. B) Representative immunoblot showing the effect of treating primary mouse cortical neurons with and without 50 μM DHPG for 5
min and pretreated either with or without tyrphostin A9 (10 μM) on Pyk2 (Y402) phosphorylation. Bar graph shows the mean ± SD of nine
independent experiments. C) Representative immunoblot showing the effect of treating primary mouse cortical neurons with and without 50
μM DHPG for 5 min and pretreated either with or without 30 μM calmidazolum chloride (CMZ) on ERK1/2 phosphorylation. Bar graph shows the
mean ± SD of five independent experiments. D) Representative immunoblot showing the effect of treating primary mouse cortical neurons with
and without 50 μM DHPG for 5 min and pretreated either with or without 30 μM calmidazolum chloride (CMZ) on Pyk2 (Y402) phosphorylation.
Bar graph shows the mean ± SD of five independent experiments. * P < 0.05 versus untreated mGluR1a expressing cells.
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quently leads to Pyk2 phosphorylation at both Tyr579
and Tyr580 and results in enhanced Pyk2 kinase activity
[28-30]. The overexpression of Pyk2 is also reported to
result in increased basal ERK1/2 phosphorylation
[28,29,31]. However, we find that in HEK293 cells basal
ERK1/2 phosphorylation is increased only when
mGluR1a is overexpressed with Pyk2. Thus, despite the
fact that Pyk2 reduces basal mGluR1a G protein cou-
pling, Pyk2 overexpression results in an increase in basal
ERK1/2 phosphorylation. In contrast, mGluR1a-
mediated ERK1/2 phosphorylation is reduced following
the expression of dominant-negative Pyk2-Y402F and
catalytically inactive Pyk2-K457A mutants. Thus, we
conclude that Pyk2 is essential for ERK1/2 phosphoryla-
tion in response to mGluR1a activation.
Both mGluR1 and mGluR5 are expressed in cortical
tissue and primary cortical neurons can be positively
stained for the expression of both mGluR1a and
mGluR5 proteins [15]. However, in primary mouse cor-
tical neurons ERK1/2 phosphorylation is selectively acti-
vated by mGluR1, as ERK1/2 phosphorylation in
response to DHPG is not inhibited by a mGluR5-speci-
fic antagonist. This is similar to what was observed by
Heidinger and colleagues [21], who demonstrated that
the phosphorylation of NMDA receptors by Pyk2 is
selectively mediated by the activation of mGluR1 and
not mGluR5 in cortical neurons. It is likely that
mGluR5 will also activate ERK1/2 phosphorylation in
other neuronal cell types for several reasons. First, Pyk2
can be co-immunoprecipitated from rat brain with
mGluR5. Second, mGluR5-mediated nociception in the
Figure 8 Effect of Staurosporine on ERK1/2 and Pyk2 phosphorylation in cortical neurons. A) Representative immunoblot showing the
effect of treating primary mouse cortical neurons with and without 50 μM DHPG for 5 min and pretreated either with or without staurosporine
(1 μM) on ERK1/2 phosphorylation. B) Representative immunoblot showing the effect of treating primary mouse cortical neurons with and
without 50 μM DHPG for 5 min and pretreated either with or without staurosporine (1 μM) on Pyk2 (Y402) phosphorylation. Bar graph shows
the mean ± SEM of five independent experiments. * P < 0.05 versus untreated mGluR1a expressing cells.
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Page 13 of 17spinal cord involves the activation of ERK1/2 and we
have recently demonstrated that mGluR5-dependent
ERK1/2 phosphorylation is increased in mutant hunting-
tin protein knockin mice [32,33]. Finally, MacDonald
and coworkers have demonstrated that mGluR5-depen-
dent activation of Pyk2 stimulates NMDA and AMPA
receptor currents in hippocampal neurons [34].
It has previously been reported that Group I mGluRs
increase the extent of Pyk2 phosphorylation in mouse
neuronal cortical cultures via a mechanism that is both
calmodulin- and Src-dependent, but that is independent
of PKC activity [21]. We find that Pyk2-mediated activa-
tion of ERK1/2 phosphorylation is both calmodulin- and
Src-dependent, but it also involves a mechanism that
requires PKC activation. Calmodulin binds to both
mGluR1 and mGluR5 in a Ca
2+-dependent manner and
can be regulated by PKC-mediated phosphorylation of
the receptor within the calmodulin binding domain
[35-37]. The identification of Pyk2 and CaM as Group I
mGluR interacting proteins suggests the possibility that
Figure 9 Effect of Pyk2 siRNA treatment on ERK1/2 phosphorylation in cortical neurons and COS7 cells. A) Representative immunoblots
showing Pyk2 protein expression, ERK1/2 phosphorylation, and Pyk2 (Y402) phosphorylation in primary mouse cortical neurons treated with 100
nM Pyk2 siRNA and stimulated with and without 50 μM DHPG stimulation for 1 min. B) Bar graph shows the densitometric analysis of ERK1/2
phosphorylation in control, Pyk2 siRNA, and scrambled (Scr) siRNA treated cortical neurons and represents the mean ± SD of five independent
experiments. C) Bar graph shows the densitometric analysis of Pyk2 (Y402) phosphorylation in control, Pyk2 siRNA, and scrambled (Scr) siRNA
treated cortical neurons and represents the mean ± SD of five independent experiments. D) Representative immunoblots showing the effect of
DHPG treatment (50 μM DHGP, 1 min) on Pyk2 protein expression, ERK1/2 phosphorylation, and Pyk2 (Y402) phosphorylation in COS7 cells
expressing either FLAG-mGluR1 alone, treated with Pyk2 siRNA alone or expressing FLAG-mGluR1a and treated with Pyk2 siRNA. E) Bar graph
shows the densitometric analysis of ERK1/2 phosphorylation in cells transfected with FLAG-mGluR1a alone, cells treated with Pyk2 siRNA alone,
and cells transfected with FLAG-mGluR1a and treated with Pyk2 siRNA. F) Bar graph shows the densitometric analysis of Pyk2 (Y402)
phosphorylation in cells transfected with FLAG-mGluR1a alone, cells treated with Pyk2 siRNA alone, and cells transfected with FLAG-mGluR1a and
treated with Pyk2 siRNA. The graph represents the mean ± SD of four independent experiments. * P < 0.05 versus untreated mGluR1a
expressing cells.
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complex that is scaffolded on the intracellular face of
mGluR1. Thus, in response to PKC-mediated phosphor-
ylation of mGluR1a, the complex may be released from
the receptor to activate ERK1/2 phosphorylation.
We also find that siRNA treatment of cortical neurons
results in a significant reduction in Pyk2 protein expres-
sion, but unexpectedly this also results in increased
basal ERK1/2 phosphorylation. The increase in ERK1/2
phosphorylation is associated with increased
phosphorylation of the remaining fraction of Pyk2 pro-
tein expressed in the neuronal cultures. The depletion
of Pyk2 expression in COS7 cells also leads to increased
basal Pyk2 phosphorylation, but mGluR1a expression is
required for this Pyk2-mediated increase in ERK/1/2
phosphorylation. The mechanism by which a loss of
Pyk2 expression leads to alterations in the phosphoryla-
tion of the residual pool of Pyk2 and increased ERK1/2
phosphorylation is unclear. However, it appears to
require mGluR1 expression suggesting that constitutive
Figure 10 Effect of Pyk2-Y402F and Pyk2 overexpression on mGluR1a-mediated ERK1/2 Phosphorylation. A) Representative
immunoblots showing, ERK1/2 phosphorylation, ERK/12 protein expression, Pyk2 (Y402) phosphorylation, Pyk2 protein expression and FLAG-
mGluR1a expression in cells transfected with and without pCDNA3.1 plasmd cDNAs encoding Flag-mGluR1a (5 μg) with and with 1 μgo f
pcDNA3.1 plasmid cDNA expressing either wild-type HA-Pyk2 or HA-Pyk2-Y402F. Cells were treated in the absence or presence of 50 μM
quisqualate at 37°C. B) Bar graph shows the densitometric analysis of ERK1/2 phosphorylation in cells either expressing FLAG-mGluR1a alone,
HA-Pyk2 alone or expressing FLAG-mGluR1a in the presence of HA-Pyk2, HA-Pyk2-Y402F and HA-Pyk2-K457A and is expressed as the mean ± SD
of 4-8 different experiments. *P <0.05 compared to basal ERK1/2 phosphorylation levels in mGluR1a expressing cells.
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Page 15 of 17mGluR1 activity underlies the phenomenon and that
Pyk2 plays a role in regulating basal mGluR1 activity.
In summary, we show here that Pyk2 interacts with
Group I mGluR1a via the intracellular loop2 and the
carboxyl-terminal tail domains of mGluR1a and func-
tions to uncouple the receptor from Gaq/11 protein,
while facilitating ERK1/2 phosphorylation. The direct
association of Pyk2 with mGluR1a appears to coordinate
the formation of a protein complex that includes Src
bound to Pyk2 and potentially calmodulin bound to the
carboxyl-terminal tail of the receptor. The formation of
this complex may be important for the spatial temporal
regulation of Pyk2 activity at post-synaptic densities that
is expected to be required for the efficient regulation of
NMDA and AMPA receptor function as well as the reg-
ulation of other ERK1/2-dependent activities in synaptic
transmission. The observation that several signaling pro-
teins, such as Pyk2, optineurin CAIN and GRK2 regu-
late mGluR signaling via their interaction with the
interface provided by the second intracellular loop sug-
gests that peptides which mimic this interface may be
useful for the modulation of Group I mGluR signaling.
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